267 related articles for article (PubMed ID: 33363541)
1. CD86 Is a Selective CD28 Ligand Supporting FoxP3+ Regulatory T Cell Homeostasis in the Presence of High Levels of CTLA-4.
Halliday N; Williams C; Kennedy A; Waters E; Pesenacker AM; Soskic B; Hinze C; Hou TZ; Rowshanravan B; Janman D; Walker LSK; Sansom DM
Front Immunol; 2020; 11():600000. PubMed ID: 33363541
[TBL] [Abstract][Full Text] [Related]
2. Targeting CD28, CTLA-4 and PD-L1 costimulation differentially controls immune synapses and function of human regulatory and conventional T-cells.
Dilek N; Poirier N; Hulin P; Coulon F; Mary C; Ville S; Vie H; Clémenceau B; Blancho G; Vanhove B
PLoS One; 2013; 8(12):e83139. PubMed ID: 24376655
[TBL] [Abstract][Full Text] [Related]
3. TCR Signaling and CD28/CTLA-4 Signaling Cooperatively Modulate T Regulatory Cell Homeostasis.
Holt MP; Punkosdy GA; Glass DD; Shevach EM
J Immunol; 2017 Feb; 198(4):1503-1511. PubMed ID: 28053234
[TBL] [Abstract][Full Text] [Related]
4. CD80 on Human T Cells Is Associated With FoxP3 Expression and Supports Treg Homeostasis.
Soskic B; Jeffery LE; Kennedy A; Gardner DH; Hou TZ; Halliday N; Williams C; Janman D; Rowshanravan B; Hirschfield GM; Sansom DM
Front Immunol; 2020; 11():577655. PubMed ID: 33488578
[TBL] [Abstract][Full Text] [Related]
5. Treg-expressed CTLA-4 depletes CD80/CD86 by trogocytosis, releasing free PD-L1 on antigen-presenting cells.
Tekguc M; Wing JB; Osaki M; Long J; Sakaguchi S
Proc Natl Acad Sci U S A; 2021 Jul; 118(30):. PubMed ID: 34301886
[TBL] [Abstract][Full Text] [Related]
6. Trans-endocytosis of CD80 and CD86: a molecular basis for the cell-extrinsic function of CTLA-4.
Qureshi OS; Zheng Y; Nakamura K; Attridge K; Manzotti C; Schmidt EM; Baker J; Jeffery LE; Kaur S; Briggs Z; Hou TZ; Futter CE; Anderson G; Walker LS; Sansom DM
Science; 2011 Apr; 332(6029):600-3. PubMed ID: 21474713
[TBL] [Abstract][Full Text] [Related]
7. Expression of costimulatory molecules CD80 and CD86 and their receptors CD28, CTLA-4 on malignant ascites CD3+ tumour-infiltrating lymphocytes (TIL) from patients with ovarian and other types of peritoneal carcinomatosis.
Melichar B; Nash MA; Lenzi R; Platsoucas CD; Freedman RS
Clin Exp Immunol; 2000 Jan; 119(1):19-27. PubMed ID: 10606960
[TBL] [Abstract][Full Text] [Related]
8. Cytotoxic T lymphocyte-associated antigen-4-Ig (CTLA-4-Ig) suppresses Staphylococcus aureus-induced CD80, CD86, and pro-inflammatory cytokine expression in human B cells.
Liu PC; Ssu CT; Tsao YP; Liou TL; Tsai CY; Chou CT; Chen MH; Leu CM
Arthritis Res Ther; 2020 Mar; 22(1):64. PubMed ID: 32228715
[TBL] [Abstract][Full Text] [Related]
9. The CD28/CTLA-4-B7 signaling pathway is involved in both allergic sensitization and tolerance induction to orally administered peanut proteins.
van Wijk F; Nierkens S; de Jong W; Wehrens EJ; Boon L; van Kooten P; Knippels LM; Pieters R
J Immunol; 2007 Jun; 178(11):6894-900. PubMed ID: 17513738
[TBL] [Abstract][Full Text] [Related]
10. Control of Memory Phenotype T Lymphocyte Homeostasis: Role of Costimulation.
Panda AK; Kim YH; Shevach EM
J Immunol; 2022 Feb; 208(4):851-860. PubMed ID: 35039334
[TBL] [Abstract][Full Text] [Related]
11. Covalent dimerization of CD28/CTLA-4 and oligomerization of CD80/CD86 regulate T cell costimulatory interactions.
Greene JL; Leytze GM; Emswiler J; Peach R; Bajorath J; Cosand W; Linsley PS
J Biol Chem; 1996 Oct; 271(43):26762-71. PubMed ID: 8900156
[TBL] [Abstract][Full Text] [Related]
12. A transendocytosis model of CTLA-4 function predicts its suppressive behavior on regulatory T cells.
Hou TZ; Qureshi OS; Wang CJ; Baker J; Young SP; Walker LS; Sansom DM
J Immunol; 2015 Mar; 194(5):2148-59. PubMed ID: 25632005
[TBL] [Abstract][Full Text] [Related]
13. Chimeric co-stimulatory molecules that selectively act through CD28 or CTLA-4 on human T cells.
Lazetic S; Leong SR; Chang JC; Ong R; Dawes G; Punnonen J
J Biol Chem; 2002 Oct; 277(41):38660-8. PubMed ID: 12167647
[TBL] [Abstract][Full Text] [Related]
14. The landscape of
de Vos L; Grünwald I; Bawden EG; Dietrich J; Scheckenbach K; Wiek C; Zarbl R; Bootz F; Landsberg J; Dietrich D
Epigenetics; 2020 Nov; 15(11):1195-1212. PubMed ID: 32281488
[TBL] [Abstract][Full Text] [Related]
15. Molecular and Cellular Functions of CTLA-4.
Van Coillie S; Wiernicki B; Xu J
Adv Exp Med Biol; 2020; 1248():7-32. PubMed ID: 32185705
[TBL] [Abstract][Full Text] [Related]
16. Activation of human peripheral blood dendritic cells induces the CD86 co-stimulatory molecule.
McLellan AD; Starling GC; Williams LA; Hock BD; Hart DN
Eur J Immunol; 1995 Jul; 25(7):2064-8. PubMed ID: 7542604
[TBL] [Abstract][Full Text] [Related]
17. Differences in CD80 and CD86 transendocytosis reveal CD86 as a key target for CTLA-4 immune regulation.
Kennedy A; Waters E; Rowshanravan B; Hinze C; Williams C; Janman D; Fox TA; Booth C; Pesenacker AM; Halliday N; Soskic B; Kaur S; Qureshi OS; Morris EC; Ikemizu S; Paluch C; Huo J; Davis SJ; Boucrot E; Walker LSK; Sansom DM
Nat Immunol; 2022 Sep; 23(9):1365-1378. PubMed ID: 35999394
[TBL] [Abstract][Full Text] [Related]
18. Multiple layers of CD80/86-dependent costimulatory activity regulate primary, memory, and secondary lymphocytic choriomeningitis virus-specific T cell immunity.
Eberlein J; Davenport B; Nguyen TT; Victorino F; Sparwasser T; Homann D
J Virol; 2012 Feb; 86(4):1955-70. PubMed ID: 22156513
[TBL] [Abstract][Full Text] [Related]
19. An important role of CD80/CD86-CTLA-4 signaling during photocarcinogenesis in mice.
Loser K; Scherer A; Krummen MB; Varga G; Higuchi T; Schwarz T; Sharpe AH; Grabbe S; Bluestone JA; Beissert S
J Immunol; 2005 May; 174(9):5298-305. PubMed ID: 15843526
[TBL] [Abstract][Full Text] [Related]
20. Targeting T cell costimulation in autoimmune disease.
Stuart RW; Racke MK
Expert Opin Ther Targets; 2002 Jun; 6(3):275-89. PubMed ID: 12223069
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
